According to the UK's Daily Mail, inventor Billy Boyle has developed a new technology that uses a breath sampler to detect the risk of cancer in the human body. It can be used to diagnose early-stage lung cancer, colon cancer, various inflammatory conditions, and infectious diseases. This invention has won the MacRobert Award and aims to save at least 100,000 lives while reducing medical costs.
According to statistics, people diagnosed with late-stage colon cancer have only a 5% chance of survival, whereas those diagnosed with cancer at an early stage may have a survival rate of around 95%.
The cancer breathalyzer invented by Boyle and his team can determine potential diseases in users by monitoring and analyzing the types of volatile organic compounds (VOCs) in their breath. VOCs are early indicators for diagnosing lung cancer, colon cancer, and various inflammatory conditions, meaning the cancer breathalyzer helps in confirming early-stage lung cancer, colon cancer, various inflammatory conditions, and infectious diseases.
This invention won the MacRobert Award on June 27, which was presented in person by Princess Anne at a ceremony held at the Tower of London. The award is hosted by the Royal Academy of Engineering and is known as the "Oscars of Engineering," representing the most prestigious engineering award in the UK. In addition to the award, Boyle and his team received a £50,000 (approximately 430,000 RMB) prize provided by the Royal Academy of Engineering.
It is well known that for diseases such as cancer, early diagnosis is crucial and can even save lives. However, current medical testing processes are painful, daunting, and costly, leading patients to avoid undergoing them. Boyle stated that this newly invented cancer breathalyzer is compact, low-cost, and highly feasible. Its goal is to save at least 100,000 lives and save the global healthcare system £1.13 billion (approximately 9.8 billion RMB). This feat may signal the beginning of a new era in cancer diagnosis, potentially revolutionizing the way we diagnose and treat diseases and reducing cancer mortality rates.
Disclaimer: The materials in this article are sourced from the internet, and the copyright belongs to the original author. If there are any copyright issues, please contact us.
